News
11-18-2014, 04:12 AM
The results from a pooled analysis of two Phase III Halaven(R) (eribulin) trials are published in Breast Cancer Research and Treatment.
More... (http://www.medicalnewstoday.com/releases/285555.php)
More... (http://www.medicalnewstoday.com/releases/285555.php)